Staphylococcus aureus is a major human pathogen that causes a wide range of clinical
infections. It is a leading cause of bacteremia and infective endocarditis as well as …

Importance Several management strategies may improve outcomes in patients
withStaphylococcus aureusbacteremia. Objectives To review evidence of management …

Background. We assessed the impact of infectious disease (ID) consultation on
management and outcome in patients with Staphylococcus aureus bacteremia (SAB) …

Objective Mortality and morbidity of Staphylococcus aureus bacteremia (SAB) still remains
considerably high. We aimed to evaluate the impact of infectious disease consultation (IDC) …

According to the WHO, more than 30 million children under five years of age still suffer from
vaccine-preventable diseases (VPDs) every year in Africa. 1 Of these, over half a million die …

Background. Staphylococcus aureus bacteremia (SAB) is associated with significant
morbidity and mortality. Several aspects of clinical management have been shown to have …

Background. Previous studies, largely based on chart reviews with small sample sizes, have
demonstrated that infectious diseases (ID) specialists positively impact patient outcomes …

According to the WHO, more than 30 million children under five years of age still suffer from
vaccine-preventable diseases (VPDs) every year in Africa. 1 Of these, over half a million die …

Background Daptomycin and ceftaroline (DAP-CPT) have been used for persistent
methicillin-resistant Staphylococcus aureus bacteremia (MRSAB), but have rarely been …

Background Findings from previous studies have suggested that outcomes after meticillin-
resistant Staphylococcus aureus (MRSA) bacteraemia are worse than after meticillin …